Mangoceuticals (MGRX) Competitors $1.82 +0.26 (+16.29%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. CCM, MRAI, ENZ, BRTX, KDLY, ATPC, SSY, OTRK, DHAC, and ATIPShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Agape ATP (ATPC), SunLink Health Systems (SSY), Ontrak (OTRK), Digital Health Acquisition (DHAC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Concord Medical Services Marpai Enzo Biochem BioRestorative Therapies Kindly MD Agape ATP SunLink Health Systems Ontrak Digital Health Acquisition ATI Physical Therapy Concord Medical Services (NYSE:CCM) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment, community ranking and analyst recommendations. Does the MarketBeat Community believe in CCM or MGRX? Concord Medical Services received 197 more outperform votes than Mangoceuticals when rated by MarketBeat users. CompanyUnderperformOutperformConcord Medical ServicesOutperform Votes19759.16% Underperform Votes13640.84% MangoceuticalsN/AN/A Do institutionals and insiders believe in CCM or MGRX? 56.7% of Mangoceuticals shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Comparatively, 16.0% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer CCM or MGRX? In the previous week, Mangoceuticals had 3 more articles in the media than Concord Medical Services. MarketBeat recorded 3 mentions for Mangoceuticals and 0 mentions for Concord Medical Services. Mangoceuticals' average media sentiment score of 1.64 beat Concord Medical Services' score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the news media. Company Overall Sentiment Concord Medical Services Neutral Mangoceuticals Very Positive Which has preferable valuation and earnings, CCM or MGRX? Mangoceuticals has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$471.70M0.04-$41.93MN/AN/AMangoceuticals$615.87K15.28-$9.21M-$4.85-0.38 Is CCM or MGRX more profitable? Concord Medical Services has a net margin of 0.00% compared to Mangoceuticals' net margin of -1,237.00%. Concord Medical Services' return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A Mangoceuticals -1,237.00%-138.00%-118.88% Which has more volatility and risk, CCM or MGRX? Concord Medical Services has a beta of -0.64, meaning that its share price is 164% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.41, meaning that its share price is 141% more volatile than the S&P 500. SummaryConcord Medical Services and Mangoceuticals tied by winning 6 of the 12 factors compared between the two stocks. Remove Ads Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.41M$2.02B$5.35B$7.58BDividend YieldN/A7.14%5.11%4.33%P/E Ratio-0.3115.0421.6517.79Price / Sales15.283.84375.8994.27Price / CashN/A9.3238.1534.64Price / Book3.374.166.443.99Net Income-$9.21M$87.49M$3.20B$247.24M7 Day Performance13.75%-0.76%6.67%5.84%1 Month Performance-53.45%-8.67%-6.27%-5.78%1 Year Performance-96.66%-27.10%8.56%-1.99% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.6589 of 5 stars$1.82+16.3%N/A-96.7%$9.41M$615,873.00-0.313Short Interest ↑Gap DownCCMConcord Medical ServicesN/A$4.20-5.4%N/A-33.0%$18.23M$471.70M0.00970Upcoming EarningsGap DownMRAIMarpaiN/A$1.00+4.2%N/A-55.2%$14.90M$34.87M-0.38150Gap UpENZEnzo BiochemN/A$0.28-2.4%N/A-70.5%$14.83M$29.09M0.00520High Trading VolumeBRTXBioRestorative Therapies3.4755 of 5 stars$1.70-0.3%$18.00+961.9%+32.8%$12.72M$377,000.00-1.117Short Interest ↓Gap DownKDLYKindly MD0.6429 of 5 stars$1.43-3.4%N/AN/A$8.62M$2.72M-2.17N/APositive NewsATPCAgape ATP1.0231 of 5 stars$1.54+26.2%N/A-70.7%$6.15M$1.32M-2.1140Gap DownSSYSunLink Health SystemsN/A$0.86-2.5%N/A+23.4%$6.02M$31.23M6.111,376OTRKOntrak2.8112 of 5 stars$1.43-1.8%$45.00+3,057.9%-71.6%$6.01M$11.24M-0.13250Earnings ReportShort Interest ↓DHACDigital Health AcquisitionN/A$1.14-4.2%N/A-91.3%$4.11MN/A0.002,021ATIPATI Physical TherapyN/A$0.89-4.3%N/A-75.6%$3.94M$741.86M-0.055,600Gap Down Remove Ads Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives ENZ Alternatives BRTX Alternatives KDLY Alternatives ATPC Alternatives SSY Alternatives OTRK Alternatives DHAC Alternatives ATIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.